Investors

Investors > FY 2022-23

Investors > FY 2022-23



1. Annual Report

Transcript of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2023
Intimation for Presentation to analysts on audited financial results for the quarter and year ended 31st March, 2023
Intimation of Record Date for the purpose of payment of final dividend for the year 2022-23
Compliance as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Secretarial Compliance Report for the year ended 31st March, 2023
Shareholding Pattern Q4
Intimation for Trading Window Closure_Q4
Disclosure Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - USFDA Pre-Approval Inspection of Oral Oncology Manufacturing facility, Gujarat
Newspaper advertisement in respect of Notice of Hearing of Petition
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and nine months ended 31st December, 2022
Intimation for Presentation to analysts on financial result for the quarter and nine months ended 31st December, 2022
Disclosure Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Shareholding Pattern Q3
Intimation of Board Meeting dated 25-01-2023
Intimation of Record Date_Interim Dividend
Intimation for Concall with Investors / Analyst Q3_2022-23
Intimation for Trading Window Closure_Q3
Intimation for approval of scheme of amalgamation of Curatio Health Care (I) Private Limited with Company
Intimation for Trading Window Closure
Partial Redemption of Non-Convertible debentures issued under ISIN INE685A07082
Payment of Interest & Partial Redemption of Non-Convertible debentures issued under ISIN INE685A07082
Press Release – Torrent Pharmaceuticals Ltd enters into co-marketing partnership with Boehringer Ingelheim India Private Limited to co- market its anti-diabetic drug and its fixed dose combinations in India
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation regarding issue of NCDs
Intimation of Credit Rating
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2022
Compliance as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Presentation to analysts on financial result for the quarter ended 30th September, 2022
Intimation for Concall with Investors / Analyst Q2_2022-23
Update on Acquisition of Curatio Health Care (I) Private Limited
Shareholding Pattern 2
Intimation of the board meeting dated 21-10-2022
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Trading Window Closure_Q2
Intimation for execution of definitive agreements in relation to acquisition of 100% stake in Curatio Health Care (I) Private Limited
Press Release – Torrent Pharma to acquire Curatio Healthcare
Intimation – Conference call with investors / analyst
Intimation – Presentation to analysts on acquisition of Curatio Health Care (I) Private Limited
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Postal Ballot Result and Scrutinizer’s Report – 09th Septmber, 2022
Redemption of Non-Convertible debentures issued under ISIN INE685A07090
Intimation of Credit Rating
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2022
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Voting Results & Scrutinizer’s Report AGM dated 29-07-2022
Newspaper advertisement of Financial Result for Q1 2022-23
Proceedings of 49th Annual General Meeting of the Company held on 29th July, 2022
Intimation for Presentation to analysts on financial result for the quarter ended 30th June, 2022
Appointment of Manish Choksi as Independent Director of the Company
Appointment of Aman Mehta as Whole-time Director of the Company
Intimation for Concall with Investors / Analyst Q1_2022-23
Allotment of Bonus Shares
Shareholding Pattern Q1
Intimation of the board meeting dated 29-07-2022
Newspaper advertisement in respect of Annual General Meeting and E-Voting Procedure
Postal Ballot Result and Scrutinizer’s Report – 01st July, 2022
Newspaper advertisement regarding Intimation of the 49th AGM of the Company through VC / OAVM facility
Intimation for Trading Window Closure_Q1
Press Release – Torrent Pharma acquires 4 Brands from Dr. Reddy’s laboratories
Update on Board Meeting
Intimation of Change in Directorate
Intimation of the Board Meeting Dated 25-05-2022
Exchange Intimation of Credit Rating
Partial Redemption of Non-Convertible Debentures issued under ISIN: INE685A07108

Details of Nodal Officer

Name : Chintan Trivedi

Designation : Company Secretary

E-mail Id : investorservices@torrentpharma.com

IEPF Authority - Refund web page

IEPF Authority - Refund web page >>